Omalizumab (anti-IgE)

Ask supplier a question | View on supplier's website

Omalizumab is a recombinant, humanized, monoclonal antibody against human immunoglobulin E (IgE) with a KD of 0.393 nM. Omalizumab binds to the human FcγRIIb receptors with a KD of 6.37 uM. Omalizumab has the potential for persistent allergic asthma research.

Supplier	Selleck Chemicals
Product #	A2044
Sku #	A2044-1mg*5
Pricing	1mg*5, $747.00

Feedback